CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells

Oncotarget

Volumn 6, Issue 1, 2015, Pages 243-257

  Wang, Shi Jie ^a   Cui, Hong Yong ^a   Liu, Yan Mei ^a   Zhao, Pu ^b   Zhang, Yang ^a   Fu, Zhi Guang ^a   Chen, Zhi Nan ^a   Jiang, Jian Li ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHEASTERN UNIVERSITY   (China)

Author keywords

CD147; DOCK8; Rac1; Src; STAT3

Indexed keywords

CD147 ANTIGEN; ONCOPROTEIN; PROTEIN DOCK8; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; BSG PROTEIN, HUMAN; DOCK8 PROTEIN, HUMAN; FOCAL ADHESION KINASE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAC1 PROTEIN, HUMAN; RHO KINASE; STAT3 PROTEIN, HUMAN;

ARTICLE; CARCINOMA CELL; CELL MOTILITY; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MESENCHYME CELL; MICROENVIRONMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; LIVER TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE; WOUND HEALING;

ANTIGENS, CD147; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LIVER NEOPLASMS; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 84921376961     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2801     Document Type: Article

References (52)

1. Kohn EC. Invasion and metastasis: biology and clinical potential. Pharmacology & therapeutics. 1991; 52(2):235-244.
2. Yilmaz M and Christofori G. Mechanisms of motility in metastasizing cells. Molecular cancer research: MCR. 2010; 8(5):629-642.
3. Price JT and Thompson EW. Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert opinion on therapeutic targets. 2002; 6(2):217-233.
4. Kopfstein L and Christofori G. Metastasis: cellautonomous mechanisms versus contributions by the tumor microenvironment. Cellular and molecular life sciences: CMLS. 2006; 63(4):449-468.
5. Vignjevic D and Montagnac G. Reorganisation of the dendritic actin network during cancer cell migration and invasion. Seminars in cancer biology. 2008; 18(1):12-22.
6. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E and Marshall CJ. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008; 135(3):510-523.
7. Parri M and Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell communication and signaling: CCS. 2010; 8:23.
8. Yamazaki D, Kurisu S and Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene. 2009; 28(13):1570-1583.
9. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB and Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. The Journal of cell biology. 2003; 160(2):267-277.
10. Sahai E and Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature cell biology. 2003; 5(8):711-719.
11. Xu J, Xu HY, Zhang Q, Song F, Jiang JL, Yang XM, Mi L, Wen N, Tian R, Wang L, Yao H, Feng Q, Zhang Y, Xing JL, Zhu P and Chen ZN. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Molecular cancer research: MCR. 2007; 5(6):605-614.
12. Li Y, Xu J, Chen L, Zhong WD, Zhang Z, Mi L, Zhang Y, Liao CG, Bian HJ, Jiang JL, Yang XM, Li XY, Fan CM, Zhu P, Fu L and Chen ZN. HAb18G (CD147), a cancerassociated biomarker and its role in cancer detection. Histopathology. 2009; 54(6):677-687.
13. Jiang JL, Chan HC, Zhou Q, Yu MK, Yao XY, Lam SY, Zhu H, Ho LS, Leung KM and Chen ZN. HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains. Cellular and molecular life sciences: CMLS. 2004; 61(16):2083-2091.
14. Kanekura T, Chen X and Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. International journal of cancer Journal international du cancer. 2002; 99(4):520-528.
15. Sun J and Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer research. 2001; 61(5):2276-2281.
16. Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, Huang W, Li Y, Cui HY, Guo YS, Tavernier J, Zhang SH, Jiang JL and Chen ZN. HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatology. 2011; 54(6):2012-2024.
17. Chen ML, Chai CY, Yeh KT, Wang SN, Tsai CJ, Yeh YT and Yang SF. Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma. Disease markers. 2011; 30(6):325-333.
18. Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, Bast RC, Mills GB and Gallick GE. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecologic oncology. 2003; 88(1):73-79.
19. Jin H, Garmy-Susini B, Avraamides CJ, Stoletov K, Klemke RL and Varner JA. A PKA-Csk-pp60Src signaling pathway regulates the switch between endothelial cell invasion and cell-cell adhesion during vascular sprouting. Blood. 2010; 116(25):5773-5783.
20. Boyce B and Xing L. Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data. Clinical investigation. 2011; 1(12):1695-1706.
21. Zhang S and Yu D. Targeting Src family kinases in anticancer therapies: turning promise into triumph. Trends in pharmacological sciences. 2012; 33(3):122-128.
22. Mathew S, George SP, Wang Y, Siddiqui MR, Srinivasan K, Tan L and Khurana S. Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. The Journal of biological chemistry. 2008; 283(33):22709-22722.
23. Huang Q, Li J, Xing J, Li W, Li H, Ke X, Zhang J, Ren T, Shang Y, Yang H, Jiang J and Chen Z. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting p53-dependent signaling pathway. J Hepatol. 2014; 61(4): 859-866.
24. Wang L and Damania B. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer research. 2008; 68(12):4640-4648.
25. Li Y, Wu J, Song F, Tang J, Wang SJ, Yu XL, Chen ZN and Jiang JL. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin beta1 to modulate malignant properties of hepatoma cells. J Biol Chem. 2012; 287(7):4759-4772.
26. Li N, Grivennikov SI and Karin M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell. 2011; 19(4):429-431.
27. Yu H, Pardoll D and Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798-809.
28. Michels S, Trautmann M, Sievers E, Kindler D, Huss S, Renner M, Friedrichs N, Kirfel J, Steiner S, Endl E, Wurst P, Heukamp L, Penzel R, Larsson O, Kawai A, Tanaka S, et al. SRC signaling is crucial in the growth of synovial sarcoma cells. Cancer research. 2013; 73(8):2518-2528.
29. Katz E, Sims AH, Sproul D, Caldwell H, Dixon MJ, Meehan RR and Harrison DJ. Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget. 2012; 3(6):608-619.
30. Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, Zha XL and Liu KD. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. Journal of cancer research and clinical oncology. 2006; 132(11):685-697.
31. Qin LX. Inflammatory Immune Responses in Tumor Microenvironment and Metastasis of Hepatocellular Carcinoma. Cancer microenvironment: official journal of the International Cancer Microenvironment Society. 2012.
32. Guo W and Giancotti FG. Integrin signalling during tumour progression. Nature reviews Molecular cell biology. 2004; 5(10):816-826.
33. Michels S, Trautmann M, Sievers E, Kindler D, Huss S, Renner M, Friedrichs N, Kirfel J, Steiner S, Endl E, Wurst P, Heukamp L, Penzel R, Larsson O, Kawai A, Tanaka S, et al. SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells. Cancer research. 2013; 73(8):2518-2528.
34. Khusial PR, Vadla B, Krishnan H, Ramlall TF, Shen Y, Ichikawa H, Geng JG and Goldberg GS. Src activates Abl to augment Robo1 expression in order to promote tumor cell migration. Oncotarget. 2010; 1(3):198-209.
35. Cote JF and Vuori K. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci. 2002; 115(Pt 24):4901-4913.
36. Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, Rauter I, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G, Dasouki M, Al-Herz W, et al. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol. 2012; 13(6):612-620.
37. Randall KL, Chan SS, Ma CS, Fung I, Mei Y, Yabas M, Tan A, Arkwright PD, Al Suwairi W, Lugo Reyes SO, Yamazaki-Nakashimada MA, Garcia-Cruz Mde L, Smart JM, Picard C, Okada S, Jouanguy E, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011; 208(11):2305-2320.
38. Lambe T, Crawford G, Johnson AL, Crockford TL, Bouriez-Jones T, Smyth AM, Pham TH, Zhang Q, Freeman AF, Cyster JG, Su HC and Cornall RJ. DOCK8 is essential for T-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011; 41(12):3423-3435.
39. Ruusala A and Aspenstrom P. Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology. FEBS Lett. 2004; 572(1-3):159-166.
40. Shamri R, Young KM and Weller PF. PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases. Allergy. 2013; 68(7):880-889.
41. Nagai Y, Osawa K, Fukushima H, Tamura Y, Aoki K, Ohya K, Yasuda H, Hikiji H, Takahashi M, Seta Y, Seo S, Kurokawa M, Kato S, Honda H, Nakamura I, Maki K, et al. p130Cas plays important roles in osteoclastic bone resorption. J Bone Miner Res. 2013.
42. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL and Chen ZN. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways. Cellular and molecular life sciences: CMLS. 2008; 65(18):2933-2942.
43. Dai JY, Dou KF, Wang CH, Zhao P, Lau WB, Tao L, Wu YM, Tang J, Jiang JL and Chen ZN. The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells. BMC cancer. 2009; 9:337.
44. Mertens AE, Roovers RC and Collard JG. Regulation of Tiam1-Rac signalling. FEBS Lett. 2003; 546(1):11-16.
45. Li R, Huang L, Guo H and Toole BP. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. Journal of cellular physiology. 2001; 186(3):371-379.
46. Caudroy S, Polette M, Nawrocki-Raby B, Cao J, Toole BP, Zucker S and Birembaut P. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clinical & experimental metastasis. 2002; 19(8):697-702.
47. Voigt H, Vetter-Kauczok CS, Schrama D, Hofmann UB, Becker JC and Houben R. CD147 impacts angiogenesis and metastasis formation. Cancer investigation. 2009; 27(3):329-333.
48. Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P and Yan L. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Molecular cancer research: MCR. 2006; 4(6):371-377.
49. Dai L, Bratoeva M, Toole BP, Qin Z and Parsons C. KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprininduced signal transduction. Int J Cancer. 2012; 131(4):834-843.
50. Chen Y, Gou X, Ke X, Cui H and Chen Z. Human tumor cells induce angiogenesis through positive feedback between CD147 and insulin-like growth factor-I. PLoS One. 2012; 7(7):e40965.
51. Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN and Bian H. HAb18G/CD147 promotes epithelialmesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug. Oncogene. 2011; 30(43):4410-4427.
52. Jiang JL, Zhou Q, Yu MK, Ho LS, Chen ZN and Chan HC. The involvement of HAb18G/CD147 in regulation of storeoperated calcium entry and metastasis of human hepatoma cells. J Biol Chem. 2001; 276(50):46870-46877.